Bio-Rad Laboratories, Inc. (BIO) vs Globus Medical, Inc. (GMED)
Bio-Rad Laboratories, Inc. and Globus Medical, Inc. are both Medical Devices companies. Bio-Rad Laboratories, Inc. and Globus Medical, Inc. are of similar size ($10.4B and $10.0B). Globus Medical, Inc. trades at the lower P/E: 18.8× against 45.7×. Globus Medical, Inc. grew revenue faster over the last twelve months: 19.7% against 1.37%. Globus Medical, Inc. has the higher net margin (17.0% vs 8.59%) and the higher return on invested capital (9.58% vs 0.49%). Across the 22 metrics below, Globus Medical, Inc. leads on 20 and Bio-Rad Laboratories, Inc. on 2.
Valuation
Profitability
| Metric | BIO | GMED | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.90% | 68.55% | 56.01% |
| Operating margin | 2.05% | 20.34% | (15.03%) |
| Net margin | 8.59% | 17.03% | (20.40%) |
| Free cash flow margin | 13.64% | 24.03% | (7.24%) |
| Return on equity | 3.11% | 11.81% | (15.32%) |
| Return on assets | 2.17% | 10.25% | (19.72%) |
| Return on invested capital | 0.49% | 9.58% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack